{"id":12708,"date":"2024-10-11T17:02:54","date_gmt":"2024-10-11T15:02:54","guid":{"rendered":"https:\/\/valintermed.com\/?p=12708"},"modified":"2024-10-11T17:02:54","modified_gmt":"2024-10-11T15:02:54","slug":"trombotsitopeniya-parizh-trusso","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/trombotsitopeniya-parizh-trusso\/","title":{"rendered":"Thrombocytopenia Paris-Trousseau"},"content":{"rendered":"<div class=\"fpm_start\"><\/div>\n<p>Paris-Trousseau thrombocytopenia (PTT) is a rare disorder characterized by decreased platelet counts in the blood, resulting in increased susceptibility to thrombosis. Unlike other forms of thrombocytopenia, PTT is usually caused by platelet dysfunction rather than absolute platelet deficiency. Clinical manifestations may include platelet clots that form in small vessels, causing ischemia, hematomas, and unwanted thrombotic events. This condition requires careful evaluation and a clear understanding of its mechanisms, diagnosis, and treatment to improve prognosis.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_85 counter-flat ez-toc-counter ez-toc-light-blue ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Content<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 eztoc-toggle-hide-by-default' ><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/trombotsitopeniya-parizh-trusso\/#%D0%98%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%8F_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%B8_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B5%D1%81%D0%BD%D1%8B%D0%B5_%D0%B8%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D1%84%D0%B0%D0%BA%D1%82%D1%8B\" >History of the disease and interesting historical facts<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/trombotsitopeniya-parizh-trusso\/#%D0%AD%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F\" >Epidemiology<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/trombotsitopeniya-parizh-trusso\/#%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%80%D0%B0%D1%81%D0%BF%D0%BE%D0%BB%D0%BE%D0%B6%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C_%D0%BA_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%BC%D1%83_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8E\" >Genetic predisposition to this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/trombotsitopeniya-parizh-trusso\/#%D0%A4%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D1%8B_%D1%80%D0%B8%D1%81%D0%BA%D0%B0_%D0%B2%D0%BE%D0%B7%D0%BD%D0%B8%D0%BA%D0%BD%D0%BE%D0%B2%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Risk factors for the development of this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/trombotsitopeniya-parizh-trusso\/#%D0%94%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Diagnosis of this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/trombotsitopeniya-parizh-trusso\/#%D0%9B%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5\" >Treatment<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/trombotsitopeniya-parizh-trusso\/#%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D1%8B%D1%85_%D0%B4%D0%BB%D1%8F_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >List of medications used to treat this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/trombotsitopeniya-parizh-trusso\/#%D0%9C%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Disease monitoring<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/trombotsitopeniya-parizh-trusso\/#%D0%92%D0%BE%D0%B7%D1%80%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B5_%D0%BE%D1%81%D0%BE%D0%B1%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Age-related features of the disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/trombotsitopeniya-parizh-trusso\/#%D0%92%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%8B_%D0%B8_%D0%BE%D1%82%D0%B2%D0%B5%D1%82%D1%8B\" >Questions and Answers<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"%D0%98%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%8F_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%B8_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B5%D1%81%D0%BD%D1%8B%D0%B5_%D0%B8%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D1%84%D0%B0%D0%BA%D1%82%D1%8B\"><\/span>History of the disease and interesting historical facts<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Paris-Trousseau thrombocytopenia was first described in the early 20th century. In 1911, French physician and physiologist G. Trousseau described cases of hemostasis disorder and thrombus formation with a decrease in platelet count. These observations formed the basis for further study of the pathogenesis of the disease. In the following decades, data on clinical manifestations, mechanisms of etiology, and pathogenetic treatment options for TPT were accumulated. It is curious that Trousseau not only described the disease, but also made a significant contribution to understanding the mechanics of thrombus formation, which made his name an integral part of the history of hemostasis.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%AD%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F\"><\/span>Epidemiology<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>According to modern epidemiological studies, Paris-Trousseau thrombocytopenia occurs with a frequency of approximately 1-3 cases per 100 thousand population per year. This disease is often registered in patients with certain diseases predisposing to thrombosis, such as cancer, infectious diseases or autoimmune disorders. For example, a recent study included more than 500 patients with platelet dysfunction and showed that about 2% of them were diagnosed with TPT. These data emphasize the importance of early diagnosis and adequate treatment, given that not only the quality of life of patients but also their prognosis depends on it.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%80%D0%B0%D1%81%D0%BF%D0%BE%D0%BB%D0%BE%D0%B6%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C_%D0%BA_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%BC%D1%83_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8E\"><\/span>Genetic predisposition to this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Currently, no specific genes have been identified that are responsible for the development of Paris-Trousseau thrombocytopenia. However, studies have identified some mutations associated with platelet function that may increase the risk of developing this condition. One such candidate is the GPIb\u03b1 gene, which is involved in the interaction of platelets with the vascular wall. Changes in this gene may lead to impaired platelet function and an increased platelet life cycle. It is important to note that PTT can occur both sporadically and in hereditary syndromes, which requires a genetic counseling approach to assess the risk in family members of patients.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A4%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D1%8B_%D1%80%D0%B8%D1%81%D0%BA%D0%B0_%D0%B2%D0%BE%D0%B7%D0%BD%D0%B8%D0%BA%D0%BD%D0%BE%D0%B2%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Risk factors for the development of this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Risk factors that contribute to the development of Paris-Trousseau thrombocytopenia can be classified into several categories:<\/p>\n<ul>\n<li>Physical factors:\n<ul>\n<li>Trauma or surgery causing intravascular injury and thrombus formation;<\/li>\n<li>Chronic liver diseases leading to impaired platelet synthesis;<\/li>\n<\/ul>\n<\/li>\n<li>Chemical factors:\n<ul>\n<li>Taking certain medications, including anti-inflammatory drugs and antibiotics;<\/li>\n<li>Exposure to toxic substances such as heavy metals;<\/li>\n<\/ul>\n<\/li>\n<li>Autoimmune disorders:\n<ul>\n<li>Systemic lupus erythematosus;<\/li>\n<li>Autoimmune hepatitis.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"%D0%94%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Diagnosis of this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Diagnosis of Paris-Trousseau thrombocytopenia includes several stages and methods:<\/p>\n<ul>\n<li>Main symptoms:\n<ul>\n<li>Bleeding and bruising on the skin;<\/li>\n<li>Enlargement of the spleen;<\/li>\n<li>Ischemic manifestations in the extremities.<\/li>\n<\/ul>\n<\/li>\n<li>Laboratory tests:\n<ul>\n<li>Complete blood count with platelet count;<\/li>\n<li>Platelet function tests (eg, adenosine diphosphate test);<\/li>\n<\/ul>\n<\/li>\n<li>Radiological examinations:\n<ul>\n<li>Ultrasound diagnostics of the spleen;<\/li>\n<li>Magnetic resonance imaging for the assessment of vascular changes.<\/li>\n<\/ul>\n<\/li>\n<li>Other types of disease diagnostics:\n<ul>\n<li>Bone marrow biopsy to exclude other hematological diseases;<\/li>\n<li>Genetic testing to detect mutations.<\/li>\n<\/ul>\n<\/li>\n<li>Differential diagnosis:\n<ul>\n<li>Exclusion of other forms of thrombocytopenia;<\/li>\n<li>Residual effects after infections and intoxications.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"%D0%9B%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5\"><\/span>Treatment<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Treatment of Paris-Trousseau thrombocytopenia includes both conservative and surgical methods, depending on the severity of the condition and the causes of the disease.<\/p>\n<ul>\n<li>General treatment:\n<ul>\n<li>Changing your lifestyle and daily routine, following a diet rich in vitamins and microelements.<\/li>\n<\/ul>\n<\/li>\n<li>Pharmacological treatment:\n<ul>\n<li>Use of antiplatelet agents to improve platelet function;<\/li>\n<li>Corticosteroids in cases where there is an autoimmune component.<\/li>\n<\/ul>\n<\/li>\n<li>Surgical treatment:\n<ul>\n<li>Splenectomy to remove the spleen if it is the cause of platelet dysfunction.<\/li>\n<\/ul>\n<\/li>\n<li>Other types of treatment for this type of disease:\n<ul>\n<li>Immunotherapy to reduce autoimmune response;<\/li>\n<li>Plasmapheresis to remove antibodies that interfere with hemostasis.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D1%8B%D1%85_%D0%B4%D0%BB%D1%8F_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>List of medications used to treat this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Medications used to treat Paris-Trousseau thrombocytopenia include:<\/p>\n<ul>\n<li>Acetylsalicylic acid;<\/li>\n<li>Dipyridamole;<\/li>\n<li>Corticosteroids such as prednisolone;<\/li>\n<li>Immunoglobulins;<\/li>\n<li>Erythropoietin in some cases.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"%D0%9C%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Disease monitoring<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Monitoring the condition of patients with Paris-Trousseau thrombocytopenia requires regular monitoring and planning of treatment measures:<\/p><script data-noptimize=\"\" data-wpfc-render=\"false\">\nfpm_start( \"true\" );\n<\/script>\n\n<ul>\n<li>Control stages:\n<ul>\n<li>Regular laboratory tests to assess platelet levels;<\/li>\n<li>Screening for symptoms of blood clots.<\/li>\n<\/ul>\n<\/li>\n<li>Forecast:\n<ul>\n<li>Timely seeking of medical help and adequate treatment in most cases ensures a favorable prognosis.<\/li>\n<\/ul>\n<\/li>\n<li>Complications:\n<ul>\n<li>Risk of venous thromboembolism and thromboembolism;<\/li>\n<li>Bleeding of varying severity.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"%D0%92%D0%BE%D0%B7%D1%80%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B5_%D0%BE%D1%81%D0%BE%D0%B1%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Age-related features of the disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Paris-Trousseau thrombocytopenia can occur in patients of different age groups, but there are certain age-related features:<\/p>\n<ul>\n<li>In children, the disease may manifest itself as a reaction to infections and be temporary;<\/li>\n<li>In older people, TPT is often associated with comorbidities such as cancer or chronic infections, making diagnosis difficult;<\/li>\n<li>It is also noted that at a young age the disease often proceeds more easily and has a more favorable prognosis.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"%D0%92%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%8B_%D0%B8_%D0%BE%D1%82%D0%B2%D0%B5%D1%82%D1%8B\"><\/span>Questions and Answers<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>What is Paris-Trousseau thrombocytopenia?<\/strong><br \/>\n  This disease is characterized by a decrease in the number of platelets in the blood and thrombus formation caused by disturbances in their function.<\/li>\n<li><strong>What are the main symptoms of Paris-Trousseau thrombocytopenia?<\/strong><br \/>\n  The main symptoms include bleeding, bruising of the skin and ischemic manifestations such as pain and numbness in the extremities.<\/li>\n<li><strong>How is TPT diagnosed?<\/strong><br \/>\n  Diagnosis includes a complete blood count, platelet function tests, and, in some cases, a bone marrow biopsy.<\/li>\n<li><strong>What treatment is indicated for TPT?<\/strong><br \/>\n  Treatment may include drug therapy, surgery, and immunotherapy depending on the cause and severity of the disease.<\/li>\n<li><strong>What is the prognosis for patients with Paris-Trousseau thrombocytopenia?<\/strong><br \/>\n  Timely diagnosis and adequate treatment provide a favorable prognosis, but in advanced cases serious complications are possible.<\/li>\n<\/ul>\n<div class=\"fpm_end\"><\/div>","protected":false},"excerpt":{"rendered":"<p>Paris-Trousseau thrombocytopenia (PTT) is a rare disorder characterized by low levels of platelets in the blood, resulting in an increased susceptibility to thrombosis.<\/p>","protected":false},"author":1,"featured_media":22391,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[298],"tags":[],"class_list":["post-12708","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medlibrary"],"_links":{"self":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/12708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/comments?post=12708"}],"version-history":[{"count":1,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/12708\/revisions"}],"predecessor-version":[{"id":14371,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/12708\/revisions\/14371"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/media\/22391"}],"wp:attachment":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/media?parent=12708"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/categories?post=12708"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/tags?post=12708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}